psa was compared to prostate acid phosphatases ( pap ) , the reference serum marker , in 162 patients including 54 patients with carcinoma of the prostate ( cp ) , 84 patients with benign hypertrophy of the prostate ( bhp ) , and 24 controls free of prostate disorders .
C0138741
psa
C0600139
carcinoma of the prostate